KR101408568B1 - Process of fermented food containing enzyme by using mixed Aspergillus oryzae and lactic acid bacteria - Google Patents
Process of fermented food containing enzyme by using mixed Aspergillus oryzae and lactic acid bacteria Download PDFInfo
- Publication number
- KR101408568B1 KR101408568B1 KR1020120060604A KR20120060604A KR101408568B1 KR 101408568 B1 KR101408568 B1 KR 101408568B1 KR 1020120060604 A KR1020120060604 A KR 1020120060604A KR 20120060604 A KR20120060604 A KR 20120060604A KR 101408568 B1 KR101408568 B1 KR 101408568B1
- Authority
- KR
- South Korea
- Prior art keywords
- mixture
- fermented
- rice
- lactic acid
- brown rice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 42
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 42
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 38
- 241000894006 Bacteria Species 0.000 title claims abstract description 20
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 19
- 239000004310 lactic acid Substances 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims abstract description 18
- 235000021107 fermented food Nutrition 0.000 title abstract description 4
- 230000008569 process Effects 0.000 title description 3
- 240000006439 Aspergillus oryzae Species 0.000 title description 2
- 235000002247 Aspergillus oryzae Nutrition 0.000 title description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 54
- 235000009566 rice Nutrition 0.000 claims abstract description 54
- 235000021329 brown rice Nutrition 0.000 claims abstract description 48
- 238000000855 fermentation Methods 0.000 claims abstract description 45
- 230000004151 fermentation Effects 0.000 claims abstract description 45
- 235000013305 food Nutrition 0.000 claims abstract description 36
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 239000000843 powder Substances 0.000 claims abstract description 15
- 238000001035 drying Methods 0.000 claims abstract description 6
- 239000008187 granular material Substances 0.000 claims abstract description 6
- 239000002775 capsule Substances 0.000 claims abstract description 5
- -1 rings Substances 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 240000007594 Oryza sativa Species 0.000 claims description 52
- 244000068988 Glycine max Species 0.000 claims description 8
- 235000010469 Glycine max Nutrition 0.000 claims description 8
- 241000208340 Araliaceae Species 0.000 claims description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 4
- 235000008434 ginseng Nutrition 0.000 claims description 4
- 244000269722 Thea sinensis Species 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 235000009569 green tea Nutrition 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 240000002900 Arthrospira platensis Species 0.000 claims description 2
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 2
- 244000163122 Curcuma domestica Species 0.000 claims description 2
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 2
- 240000000599 Lentinula edodes Species 0.000 claims description 2
- 235000001715 Lentinula edodes Nutrition 0.000 claims description 2
- 240000000249 Morus alba Species 0.000 claims description 2
- 235000008708 Morus alba Nutrition 0.000 claims description 2
- 235000002789 Panax ginseng Nutrition 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims description 2
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 2
- 235000003373 curcuma longa Nutrition 0.000 claims description 2
- 235000008397 ginger Nutrition 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 229940082787 spirulina Drugs 0.000 claims description 2
- 238000010025 steaming Methods 0.000 claims description 2
- 235000013976 turmeric Nutrition 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims 1
- 235000013339 cereals Nutrition 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 abstract description 10
- 238000010521 absorption reaction Methods 0.000 abstract description 9
- 239000013543 active substance Substances 0.000 abstract description 6
- 102000038379 digestive enzymes Human genes 0.000 abstract description 4
- 108091007734 digestive enzymes Proteins 0.000 abstract description 4
- 230000001079 digestive effect Effects 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 3
- 238000010298 pulverizing process Methods 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 239000000835 fiber Substances 0.000 abstract description 2
- 230000031891 intestinal absorption Effects 0.000 abstract description 2
- 241000209094 Oryza Species 0.000 abstract 2
- 239000000047 product Substances 0.000 description 41
- 230000000694 effects Effects 0.000 description 26
- 239000000243 solution Substances 0.000 description 13
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 108091005804 Peptidases Proteins 0.000 description 8
- 239000004365 Protease Substances 0.000 description 8
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 8
- 230000029087 digestion Effects 0.000 description 7
- 150000008442 polyphenolic compounds Chemical class 0.000 description 7
- 235000013824 polyphenols Nutrition 0.000 description 7
- 239000012085 test solution Substances 0.000 description 7
- 239000004382 Amylase Substances 0.000 description 6
- 102000013142 Amylases Human genes 0.000 description 6
- 108010065511 Amylases Proteins 0.000 description 6
- 235000019418 amylase Nutrition 0.000 description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 229940074391 gallic acid Drugs 0.000 description 3
- 235000004515 gallic acid Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 241000473391 Archosargus rhomboidalis Species 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 241000371652 Curvularia clavata Species 0.000 description 2
- 206010019133 Hangover Diseases 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003627 anti-cholesterol Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 239000010903 husk Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- WXTPOHDTGNYFSB-RMPHRYRLSA-N (2s,3r,4s,5s,6r)-2-(3,5-dihydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1 WXTPOHDTGNYFSB-RMPHRYRLSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- 206010006500 Brucellosis Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000224466 Giardia Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- WXTPOHDTGNYFSB-UHFFFAOYSA-N Phlorin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1 WXTPOHDTGNYFSB-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- CIWCLEPRSTVDFI-UHFFFAOYSA-N [H]OOC([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C Chemical compound [H]OOC([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C CIWCLEPRSTVDFI-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000014105 formulated food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 황국균 및 유산균 복합발효기술을 적용한 발효효소식품 및 이의 제조방법에 관한 것으로서, 구체적으로 상기 발효효소식품의 제조는, 현미 및 미강을 혼합한 혼합물을 증숙하는 단계; 상기 혼합물에 황국균 및 유산균을 접종하여 발효하는 단계; 상기 발효물을 건조하는 단계; 및 상기 건조된 발효물을 분쇄한 후 과립, 분말, 환, 캡슐 및 정제로 이루어진 군으로부터 선택되는 어느 하나의 제형으로 가공하는 단계를 포함하며, 상기 제조방법에 의해 제조된 발효효소식품은 황국균 및 유산균의 복합발효를 통하여 체내 흡수율이 낮은 현미와 미강의 생리활성 물질과 섬유질이 분해되어 인체 내 흡수율이 향상되고, 소화효소에 의해 소화작용이 증진되며, 소화시 유용성분의 체내 흡수율 향상 및 항산화 효능의 효과가 우수하므로, 현대인의 영양 불균형을 해결하고, 영양 및 생리활성 성분의 장내 흡수율을 증진시킨 발효식품으로서 유용하게 이용할 수 있다.The present invention relates to a fermented enzyme food using a combined fermentation technology of Hwanggyu gum and lactic acid bacteria and a method for preparing the fermented enzyme food. Specifically, the fermented enzyme food is prepared by mixing a mixture of brown rice and rice gum; Fermenting the mixture by inoculating Hwang Gukguk and lactic acid bacteria; Drying the fermentation product; And pulverizing the dried fermented product, and then processing the fermented product into any one form selected from the group consisting of granules, powders, rings, capsules, and tablets, wherein the fermented enzyme food prepared by the above- Through the combined fermentation of lactic acid bacteria, the physiologically active substances and fibers of brown rice and rice bran, which have low absorption rate in the body, are decomposed to improve the absorption rate in the human body, the digestive action is enhanced by the digestive enzymes, It is possible to effectively utilize it as a fermented food which solves the nutritional imbalance of modern people and improves the intestinal absorption rate of nutrition and physiologically active ingredient.
Description
본 발명은 현미 및 미강에 황국균(Aspergillus oryzae) 및 유산균(lactic acid bacteria) 복합발효기술을 이용한 발효효소식품의 제조 방법에 관한 것이다.
The present invention relates to a method for producing Aspergillus oryzae and a lactic acid bacteria complex fermentation technology.
현대인의 식생활은 인스턴트식품과 가공식품의 소비가 주를 이루고 이로 인해 영양 불균형 현상과 비만 또는 각종 성인병 문제가 발생하고 있다. 이는 개인의 문제 일뿐 아니라 국민 건강을 위협하는 문제이므로 적절한 영양 균형을 유지할 수 있는 식품의 섭취가 필요하다.The consumption of instant foods and processed foods is the main food consumption of modern people, and nutritional imbalance and obesity or various adult diseases are caused by this. This is not only a personal problem, but also a threat to public health, so it is necessary to consume foods that can maintain proper nutritional balance.
현미의 미강층을 아홉 번 도정하여 만든 10분 도미를 백미라고 부르는데, 쌀 영양소의 95%는 쌀 표피층, 즉 쌀눈과 미강에 함유되어 있다. 현미는 1분 도미라고도 부르며, 벼에서 겉 부분인 왕겨를 벗겨낸 것이다. 따라서, 쌀눈과 미강을 그대로 가지고 있어 탄수화물, 지방, 단백질, 비타민, 칼슘 등이 풍부한 완전식품이라 할 수 있으며, 완전식품인 현미를 통해 영양균형을 이루고, 미강이 갖는 기능성 성분들을 통해 다양한 생리활성효과를 기대할 수 있다. 특히, 현미의 성분 중 식이섬유는 변비, 식후 혈당상승 방지, 대장암 예방 효능이 있으며, 토코트리에놀은 항산화작용, 자외선 보호작용, 콜레스테롤 증가 억제 효과를 나타낸다고 알려져 있다. 감마-오리자놀은 활성산소제거, 피지 분비 및 혈행촉진 효능이 있고, 피틴산은 지방연소작용, 항암, 신장 및 간장 기능강화, 빈혈방지, 고혈압 방지, 멜라닌 색소 생성억제 능력이 있으며, 가바(GABA)는 혈행 개선, 중성지방 억제, 비만억제, 피부개선, 혈압개선, 소취, 신경진정, 치매 예방과 개선의 효과를 나타낸다. 현미에 포함된 이노시톨은 지방간, 동맥경화 방지, 페루릭산은 활성산소 제거, 멜라닌 색소 생성억제, 옥타코사놀은 콜레스테롤 감소, 글리코겐 증가로 인한 피로회복, 비타민 B2는 세포분열촉진, 비타민 B6는 표피세포 원료 단백 대사촉진, 비타민 E는 활성산소 해독, 칼륨은 고혈압 방지, 칼슘은 골다공증 방지, 아연은 동맥경화 방지, 마그네슘은 심장병 방지, 철은 빈혈방지 등의 효능이 있는 것으로 알려져 있다. The 10-minute sea bream made nine times with rice bran in the brown rice is called white rice. 95% of the rice nutrients are contained in rice skin layer, that is, rice husk and rice bran. Brown rice is also called 1 minute sea bream, and the rice husk is peeled off from the outside of the rice. Therefore, it can be said that it is a complete food rich in carbohydrate, fat, protein, vitamins, calcium and the like because it has rice as well as rice gruel. It has nutritional balance through whole rice, brown rice, Can be expected. Especially, among the components of brown rice, dietary fiber has constipation, prevention of postprandial hyperglycemia, prevention of colorectal cancer, and tocotrienol is known to exhibit antioxidant activity, ultraviolet protective effect and cholesterol increase inhibitory effect. Gamma-orizanol has active oxygen elimination, sebum secretion and blood circulation promotion effect, and phytic acid has ability of fat burning action, anti-cancer, strengthening of kidney and liver function, prevention of anemia, prevention of hypertension and inhibition of melanin pigment formation, Blood circulation improvement, neutral fat suppression, obesity suppression, skin improvement, blood pressure improvement, deodorization, nerve sedation, prevention and improvement of dementia. The inositol contained in the brown rice is fatty liver, arteriosclerosis, prevention, Peru rigs acid radicals removal, melanin generation inhibition, oktakosanol cholesterol reduction, fatigue caused by glycogen increases, vitamin B 2 promotes cell division and vitamin B 6 are epidermal cells It is known that vitamin E promotes the metabolism of raw materials, vitamin E inhibits active oxygen, potassium prevents hypertension, calcium prevents osteoporosis, zinc prevents arteriosclerosis, magnesium prevents heart disease and iron prevents anemia.
따라서, 쌀이 주식인 한국인은 도정 과정 중 쌀눈과 미강의 소실이 없는 현미를 섭취하는 것이 건강을 영위하기 위한 바람직한 식생활이 될 것이다. 그러나, 이러한 건강상 이익에도 불구하고 현미보다는 백미의 소비량이 많은 것이 현재 우리나라 쌀 소비추세이다. 이는 백미가 현미보다 영양학적으로 우수하지는 않으나 밥맛이 좋고 소화가 잘 되기 때문이다. Therefore, Koreans who are rice stocks will have a desirable diet for health to consume rice brown rice and brown rice without loss of rice bran during the rice cultivation process. However, in spite of these health benefits, consumption of white rice is higher than that of brown rice. This is because white rice is not nutritional superior to brown rice but it is good in taste and digestion is good.
이에 따라, 상기 언급한 바와 같이, 현미는 소화가 잘 되지 않고 밥을 지었을 때 까슬까슬한 식감을 갖고 있다는 단점이 있어 백미에 비해 소비량이 많지 않으며, 현미를 도정하는 과정에서 생산되는 미강 또한 대부분 그대로 버려지거나 가축의 사료로 이용되고 있으므로, 국민의 영양균형과 건강증진을 위하여 현미 소비 및 미강의 활용 방법을 모색할 필요가 있다.
Accordingly, as mentioned above, brown rice has a disadvantage in that it has a strong texture when it is cooked and does not digest well. Therefore, consumption of rice is not much compared to that of white rice, Since it is used as an abandoned or livestock feed, it is necessary to seek ways to use brown rice and rice bran for nutrition and health promotion of the people.
본 발명의 목적은 기존의 현미 및 미강이 가지고 있는 다양한 영양성분을 통해 현대인의 영양 불균형을 해결하고, 영양 및 생리활성 성분의 장내 흡수율을 증진시키기 위하여 현미 및 미강에 황국균과 유산균의 복합발효를 적용한 발효효소식품 및 이의 제조방법을 제공하기 위한 것이다.
The object of the present invention is to solve the nutritional imbalance of modern people through various nutritional components of conventional brown rice and rice bran and to apply complex fermentation of Hwangguk-gyun and lactic acid bacteria to brown rice and rice bran in order to improve the intestinal absorption rate of nutrition and physiologically active ingredients Fermented enzyme food and a method for producing the same.
상기 목적을 달성하기 위하여, 본 발명은 In order to achieve the above object,
현미 및 미강을 혼합한 혼합물을 증숙하는 단계;Mixing the mixture of brown rice and rice bran;
상기 혼합물에 황국균 및 유산균을 접종하여 발효하는 단계;Fermenting the mixture by inoculating Hwang Gukguk and lactic acid bacteria;
상기 발효물을 건조하는 단계; 및Drying the fermentation product; And
상기 건조된 발효물을 분쇄한 후 과립, 분말, 환, 캡슐 및 정제로 이루어진 군으로부터 선택되는 어느 하나의 제형으로 가공하는 단계를 포함하는 발효효소식품의 제조방법을 제공한다.And pulverizing the dried fermented product, and then processing the fermented enzyme food into any one form selected from the group consisting of granules, powders, rings, capsules and tablets.
본 발명의 바람직한 구현 예에 있어서, 상기 현미 및 미강의 혼합물은 현미와 미강을 분쇄한 분말 형태일 수 있고, 분쇄 과정 없이 그대로 사용할 수도 있다. 상기 현미 및 미강은 수확기 이후 저장된 것을 기간에 상관없이 모두 사용할 수 있다. In a preferred embodiment of the present invention, the mixture of brown rice and rice bran may be in the form of a powder obtained by pulverizing brown rice and rice bran, and may be used as it is without grinding. The brown rice and the rice bran can be stored after harvest regardless of the period.
상기 현미 및 미강을 혼합한 혼합물은 혼합물 총 중량에 대하여 미강 1 내지 40 중량%, 및 현미 1 내지 60 중량%를 포함하는 것이 바람직하나 이에 한정되지 않으며, 상기 혼합물에는 대두가 추가로 포함될 수 있다. 이때, 추가로 포함될 수 있는 대두는 혼합물 총 중량에 대하여 1 내지 15 중량%의 함량인 것이 바람직하나 이에 한정되지 않는다.Preferably, the mixture of brown rice and rice bran comprises 1 to 40% by weight of rice bran and 1 to 60% by weight of brown rice based on the total weight of the mixture, but the mixture may further include soybeans. At this time, soybeans which may be further contained are preferably contained in an amount of 1 to 15% by weight based on the total weight of the mixture, but are not limited thereto.
본 발명의 한 구현 예에 있어서, 상기 현미 및 미강 혼합물은 100 내지 120℃ 온도에서 0.5 내지 3시간 동안 증숙하는 것이 바람직하나, 증자된 현미 및 미강을 사용할 경우에는 증숙 단계는 생략할 수 있다. 현미와 미강 혼합물을 증숙함으로써 살균효과와 호화작용을 통해 잡균의 발생을 막고, 황국균 및 유산균이 보다 잘 증식할 수 있도록 한다.In one embodiment of the present invention, the brown rice and the rice bran mixture are preferably mixed at a temperature of 100 to 120 ° C for 0.5 to 3 hours. However, when boiled brown rice and rice bran are used, the boiling step may be omitted. By mixing the mixture of brown rice and rice bran, it prevents the occurrence of germs by sterilizing effect and gentle action, and it makes it possible for the germs and lactobacillus to multiply better.
상기 방법에 있어서, 발효에 사용되는 황국균 및 유산균은 천연 배지에 액체 배양한 생균을 그대로 접종하거나, 황국균 포자분말 및 동결건조 형태의 유산균 분말과 같은 분말화된 균주를 사용할 수도 있다. 상기 황국균과 유산균은 각각 혼합물 총 중량에 대하여 0.1 내지 1.0 중량%로 접종하는 것이 바람직하고, 0.5 중량%로 접종하는 것이 더욱 바람직하나 이에 한정되지 않는다. 균주를 접종하여 발효하기 전에 상기 혼합물의 수분 함량이 혼합물의 총 중량에 대하여 55 내지 60 중량%가 되도록 수분 함량을 조절하는 단계를 추가로 포함하는 것이 바람직하다. 황국균 및 유산균의 액체 배양액을 사용할 경우에는 배양액의 수분을 고려하여 전체 수분함량을 조절하여야 한다.In the above method, as for Hwang guk gyun and lactic acid bacteria used for fermentation, the live bacteria cultured in a natural medium may be inoculated intact, or powdered strains such as Hwang gukgwon spore powder and freeze-dried lactic acid bacteria powder may be used. Preferably, the Hwang guk gyun and the lactic acid bacterium are inoculated in an amount of 0.1 to 1.0 wt% based on the total weight of the mixture, more preferably 0.5 wt%, but are not limited thereto. Preferably, the step further comprises the step of adjusting the moisture content such that the water content of the mixture is 55 to 60% by weight based on the total weight of the mixture before inoculation and fermentation of the strain. When using liquid cultures of Hwanggyu gum and lactic acid bacteria, the total moisture content should be controlled considering the moisture content of the culture.
본 발명의 또 다른 구현 예에 있어서, 황국균 및 유산균을 접종한 현미 및 미강 혼합물은 30 내지 35℃에서 48 내지 72시간 동안 발효하는 것이 바람직하다. 발효 온도를 30 내지 35℃로 유지하는 것은, 발효 온도가 35℃보다 높은 고온일 경우 유산균의 생육이 저해되거나 흑국이 발생될 가능성이 있고, 30℃ 미만일 경우 발효 효율이 떨어지기 때문이다. 또한, 48 내지 72시간의 발효 과정을 거침으로써, 유산균을 증가시킬 수 있을 뿐만 아니라, 균주의 생육에 따른 효소 생성으로 인한 영양분 및 생리활성 물질의 체내 흡수율을 높일 수 있다. 발효 시간이 48시간 미만이면 발효가 충분히 진행될 수 없고, 72시간을 초과하면 미생물의 증식속도가 현저하게 낮아지고 발효물의 건조가 시작되어 발효효율이 떨어질 수 있다.In another embodiment of the present invention, the brown rice and the rice germ mixture inoculated with Hwang Kyu-kun and lactic acid bacteria are preferably fermented at 30-35 ° C for 48-72 hours. Keeping the fermentation temperature at 30 to 35 占 폚 is because if the fermentation temperature is higher than 35 占 폚, the growth of the lactic acid bacteria may be inhibited or the blackening may occur. If the fermentation temperature is lower than 30 占 폚, the fermentation efficiency is lowered. In addition, by fermentation for 48 to 72 hours, not only can the lactic acid bacteria be increased, but also the nutrients and the bioavailability of the physiologically active substance due to the production of the enzyme can be increased by the growth of the strain. If the fermentation time is less than 48 hours, the fermentation can not proceed sufficiently. If the fermentation time exceeds 72 hours, the growth rate of the microorganism is remarkably lowered, and the fermentation product starts drying and the fermentation efficiency may be lowered.
상기와 같이 발효를 마친 발효물을 40 내지 50℃의 온도에서 5 내지 10시간 동안 건조시키는 것이 바람직하나 이에 한정되는 것은 아니다.The fermentation product thus fermented is preferably dried at a temperature of 40 to 50 DEG C for 5 to 10 hours, but is not limited thereto.
본 발명의 바람직한 구현 예에 따르면, 건조된 발효물을 분쇄한 후 부원료 및 수분을 추가로 혼합하여 가공할 수 있다. 상기 부원료로는 스피루리나, 은행, 댓잎, 표고버섯, 도토리, 녹차, 생강, 강황, 칡, 인삼, 홍삼, 뽕잎, 더덕, 송화가루, 솔잎, 도라지, 감태, 및 비타민 B군으로 이루어진 군으로부터 선택되는 어느 하나 이상을 사용할 수 있으나, 이에 한정되지 않으며, 본 발명의 발효효소식품의 효능을 방해하지 않으면서 기능성을 향상시킬 수 있는 물질이라면 모두 사용가능하다. According to a preferred embodiment of the present invention, the dried fermented product can be crushed and then further processed and mixed with additives and moisture. Examples of the additives include at least one selected from the group consisting of spirulina, bank, giardia, shiitake, acorn, green tea, ginger, turmeric, ginseng, ginseng, red ginseng, mulberry leaf, Any one or more of them can be used, but the present invention is not limited thereto, and any substance can be used as long as it can improve the functionality without hindering the efficacy of the fermented enzyme food of the present invention.
상기 발효물을 분쇄한 후 이를 과립, 분말, 환, 캡슐 또는 정제와 같은 제형으로 가공함으로써 섭취가 용이하도록 할 수 있다. 또한, 제형화된 식품은 그대로 섭취할 수도 있으나, 제품 유통기한과 지속적인 품질 유지를 위하여 건조 과정을 거치는 것이 바람직하고, 40 내지 50℃의 온도에서 5 내지 10시간 동안 건조시키는 것이 더욱 바람직하나 이에 한정되지 않는다.The fermented product may be pulverized and then processed into a formulation such as granules, powders, pills, capsules or tablets to facilitate ingestion thereof. In addition, although the formulated food may be taken intact, it is preferable to undergo a drying process for maintaining the shelf life and continuous quality of the product, and it is more preferable to dry for 5 to 10 hours at a temperature of 40 to 50 ° C, It does not.
본 발명의 구체적인 구현 예에 따르면, 상기 제조방법으로 제조된 본 발명의 발효효소식품은 시판제품과 비교하여 소화효소에 의한 소화작용을 증진시키며(도 3 및 도 4 참조), 항산화 효능이 향상된다(도 5 내지 도 6 참조). 이는 상기 제조방법에 의해 제조된 발효효소식품이 황국균과 유산균의 복합발효를 통하여 체내 흡수율이 낮은 현미와 미강의 생리활성 물질과 영양성분의 흡수를 높여줄 수 있고, 발효에 의해 체내 이용률을 증가시킬 수 있음을 나타낸다. 또한, 현미와 미강에는 섬유소가 포함되어 있는데, 이는 당흡수를 억제하여 혈당조절 등의 효과를 나타낼 수 있고, 옥사코사놀, 감마오리자놀, 리놀렌산, 알파 토코페롤, 피틴산, 페롤릭산 등의 생리활성 물질로 인해 항고혈압 활성, 항콜레스테롤 활성, 중금속 해독 활성, 및 숙취 해소 활성 등의 생리작용이 활성화되어 건강 유지의 효과를 나타낼 수 있다.According to a specific embodiment of the present invention, the fermented enzyme food of the present invention produced by the above-described method improves digestion by digestive enzymes (see FIG. 3 and FIG. 4) (See Figs. 5 to 6). The fermentation enzyme food prepared by the above method can increase the absorption of physiologically active substances and nutrients of brown rice and rice bran with low water uptake rate through the combined fermentation of Hwang Gukguk and lactic acid bacteria and increase the bioavailability by fermentation . In addition, brown rice and rice bran contain fiber, which can suppress the absorption of glucose and can exhibit effects such as blood sugar control, and can be used as physiologically active substances such as oxacosanol, gamma orzanol, linolenic acid, alpha tocopherol, phytic acid, ferulic acid The antihypertensive activity, the anti-cholesterol activity, the heavy metal detoxifying activity, and the hangover activity can be activated, and thus the effect of maintaining health can be shown.
따라서, 상기와 같은 본 발명의 제조방법은 소화가 잘되고 체내 흡수율이 높을 뿐만 아니라, 양질의 영양소가 체내에 잘 흡수되며 항산화 물질의 활성이 증가된 현미 및 미강 함유 발효효소식품의 제조를 위해 유용하게 이용될 수 있다.
Therefore, the production method of the present invention as described above is useful for the production of fermented food products containing both brown rice and rice bran fermented with good digestion and high absorption rate in the body, high quality nutrients absorbed into the body and activity of antioxidants increased Can be used.
아울러, 본 발명은 상기 제조방법에 의해 제조된 발효효소식품을 제공한다.In addition, the present invention provides a fermented enzyme food prepared by the above production method.
상기 발효효소식품은 상기 제조방법에 의해, 현미와 미강 혼합물을 황국균 및 유산균을 이용하여 복합발효시킨 것으로서, 발효물을 과립, 분말, 환, 캡슐 또는 정제와 같은 제형으로 가공함으로써 섭취가 용이하도록 제조될 수 있다.The fermented enzyme food is a fermented product obtained by compounding fermented brown rice and rice bran mixture using Hwang Gukguk and lactic acid bacteria by the above production method and processing the fermented product into a formulation such as granule, powder, ring, capsule or tablet to facilitate ingestion .
본 발명의 바람직한 구현 예에 있어서, 상기 발효효소식품은 복합발효과정을 통한 효소 생성으로 인해 체내 흡수율이 낮은 현미와 미강의 영양성분과 기능성 성분의 흡수 및 체내 이용률이 높아지고, 소화효소에 의한 소화작용 및 항산화 효능이 우수하므로, 현미 및 미강의 생리활성 물질의 이용 및 효과를 향상시킨 발효식품으로서 유용하게 이용될 수 있다.
In a preferred embodiment of the present invention, the fermentation enzyme food has high absorption and bioavailability of nutrients and functional ingredients of brown rice and rice bran with low absorption rate in the body due to production of enzyme through complex fermentation process, and digestion by digestive enzymes And antioxidant activity, it can be usefully used as a fermented food having improved use and effect of physiologically active substances of brown rice and rice bran.
상기와 같이, 현미와 미강을 황국균 및 유산균을 이용하여 복합발효함으로써, 현미에 존재하는 미네랄과 비타민의 활성도가 증가하고, 현미와 미강에 함유된 효소와 미생물에 의해 생산된 효소에 의해 현미와 미강을 소화가 잘되는 형태로 변화시켜 이의 소화를 도와주며, 현대인의 영양 불균형을 개선시켜 줄 뿐만 아니라, 체내 흡수율이 낮은 현미와 미강의 영양성분과 기능성 성분의 흡수를 높여주어 체내 이용율이 증가되므로, 현미와 미강에 포함된 생리활성 물질로 인해 항고혈압 활성, 항콜레스테롤 활성, 중금속 해독 활성, 또는 숙취해소 활성 등의 생리작용이 활성화되어 건강 유지의 효과를 나타낼 수 있다.
As described above, the activity of minerals and vitamins present in brown rice is increased by combined fermentation of brown rice and rice gang using Hwangguk and lactobacillus, and enzymes contained in brown rice and rice bran and enzymes produced by microorganisms produce brown rice and brown rice To improve digestion of digestion by helping digestion of digestive juice. It not only improves the nutritional imbalance of modern people but also improves absorption of nutrients and functional ingredients of brown rice and rice gruel which have low absorption rate in the body, And physiologically active substances contained in the rice bran can activate the physiological actions such as antihypertensive activity, anticholesterol activity, heavy metal detoxifying activity, or hangover resolution activity, thus showing the effect of maintaining health.
도 1은 본 발명의 발효효소식품 제조방법의 간략한 공정도를 나타낸 도면이다.
도 2는 발효시간에 따른 발효물의 형상을 나타낸 도면이다.
도 3은 발효효소식품과 시판제품의 아밀라제 활성을 나타낸 도면이다.
도 4는 발효효소식품과 시판제품의 프로테아제 활성을 나타낸 도면이다.
도 5는 발효효소식품과 시판제품의 폴리페놀 함량을 나타낸 도면이다.
도 6은 8배 희석한 본 발명의 발효물과 수돗물에 각각 못을 담가 항산화 효능을 확인한 도면이다.BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a simplified process diagram of a fermentation enzyme food manufacturing method of the present invention. Fig.
2 is a view showing the shape of a fermented product according to fermentation time.
FIG. 3 is a diagram showing amylase activity of fermented enzyme foods and commercial products. FIG.
4 is a diagram showing the fermentation enzyme food and the protease activity of a commercial product.
Fig. 5 is a graph showing the content of polyphenols in fermented enzyme foods and commercial products. Fig.
FIG. 6 shows antioxidant efficacy by immersing nails in a fermented product of the present invention diluted 8-fold and tap water, respectively.
이하, 본 발명을 실시예 및 실험예를 통하여 상세히 설명한다. Hereinafter, the present invention will be described in detail with reference to Examples and Experimental Examples.
단, 하기 실시예 및 실험예는 본 발명을 더욱 구체적으로 설명하기 위한 것일 뿐, 본 발명의 범위가 이들 실시예 및 실험예에 의해 한정되는 것은 아니다.
However, the following examples and experimental examples are intended to further illustrate the present invention, and the scope of the present invention is not limited by these examples and experimental examples.
<< 실시예Example 1> 발효효소식품의 제조 1> Production of fermented enzyme food
현미와 미강을 분쇄하여 현미 80 내지 90 메쉬, 미강 50 내지 60 메쉬 분말로 준비한 다음, 현미 분말 1 내지 60 중량%와 미강 분말 1 내지 40 중량%를 혼합하여 100 내지 120℃로 0.5 내지 3시간 동안 증숙하거나 시중에 증자하여 판매하는 증자분말원료를 혼합하여 발효하였다. 그런 다음, 증숙한 현미 및 미강 혼합물에 대두분말(80 내지 90 메쉬)을 1 내지 15 중량% 혼합하고 0.5 중량%의 황국균과 유산균을 접종한 후 전체 수분 함량을 55 내지 60%로 맞추었다. 이렇게 배합된 원료를 30 내지 35℃ 발효실에서 32 내지 72시간 동안 발효하여 발효물을 만들었다. 발효 후 약 24 내지 32시간이 경과하면 발효물에 균이 자라 하얗게 변하는 것을 유관으로 확인할 수 있으며, 발효시간이 48시간 정도 경과하면 녹색으로 포자가 피기 시작하는 것을 볼 수 있었다. 60 내지 72시간 동안 발효를 진행하면 발효물이 황국포자로 덮여 전체적으로 녹색을 띄게 되는데, 이 후로는 미생물의 증식속도가 현저하게 낮아지고 발효물의 건조가 시작되어 발효효율이 떨어졌다(도 2). 60 내지 72시간의 발효과정을 거친 후 발효물을 40 내지 50℃ 건조기에서 5 내지 10시간 동안 건조하여 발효를 종료시켰다. 그런 다음, 건조된 발효물을 분쇄한 후 부원료와 수분을 혼합하여 과립 또는 환의 형태로 제형화하였고, 보관의 용이성 및 저장성 증가를 위해 제형화한 제품을 40 내지 50℃ 건조기에서 다시 최종건조시켜 발효효소식품을 제조하였다.
Brown rice and rice bran are crushed to prepare
<< 실험예Experimental Example 1> 발효효소식품의 소화효소 효능의 확인 1> Confirmation of digestive enzyme efficacy of fermented enzyme food
<1-1> <1-1> 아밀라아제Amylase 활성 측정 Active measurement
상기 실시예 1에서 제조한 발효효소식품의 소화효소 효능을 확인하기 위하여, 국내 C사 제품과 발효효소식품의 아밀라아제 활성을 측정하였다. 이때, C사 제품은 현미와 미강을 황국을 이용하여 발효한 것이었다. 발효효소식품과 국내 C사 제품을 각각 1g씩 측량한 후 포스페이트 완충용액(pH 6.7) 10 ㎖을 가하고 상온에서 40분간 교반하여 조효소액을 추출하였다. 추출한 조효소액을 3,200 rpm에서 10분간 원심분리하여 고체분말을 가라앉힌 후 상층액을 Whatman filter paper(No1)로 여과하여 실험에 사용할 시험액을 얻었다. 가용성 전분 플레이트(Soluble starch plate)는 1% 가용성 전분과 2% 아가 파우더를 용해한 후 121℃에서 15분간 멸균한 것을 페트리 디쉬에 분주하여 제조하였으며, 전분 발색에 사용할 루골요오드용액은 요오드 1 g과 요오드화칼륨 2 g을 정제수 300 ㎖에 용해하여 제조하였다. 즉, 요오드화칼륨 2 g을 5 ㎖ 가량의 정제수에 충분히 용해한 후 여기에 요오드 1 g을 혼합하여 완전히 용해하고 나머지 정제수를 첨가하여 제조하였다. 제조된 루골요오드용액은 햇빛을 차광해서 저장하였다.In order to confirm the digestive enzymatic efficacy of the fermented enzyme food prepared in Example 1, the amylase activity of the fermented enzyme food and the products of the domestic C company was measured. At this time, the products of Company C were fermented using brown rice and rice gruel. Fermentation enzyme food and domestic C products were weighed 1 g each, 10 ml of phosphate buffer solution (pH 6.7) was added, and the crude enzyme solution was extracted by stirring at room temperature for 40 minutes. The extracted crude enzyme solution was centrifuged at 3,200 rpm for 10 minutes to allow the solid powder to settle, and the supernatant was filtered with Whatman filter paper (No. 1) to obtain a test liquid to be used for the experiment. The soluble starch plate was prepared by dissolving 1% soluble starch and 2% agar powder in sterilized sterilized at 121 ° C for 15 minutes. Petri dishes were prepared by dissolving 1 g of iodine and 1 g of iodine 2 g of potassium was dissolved in 300 ml of purified water. That is, 2 g of potassium iodide was sufficiently dissolved in 5 ml of purified water, and 1 g of iodine was mixed with it to completely dissolve it, followed by addition of the remaining purified water. The Brucella iodine solution was stored in the sunshine.
효소활성의 측정은 가용성 전분 플레이트에 발효효소식품 및 C사 제품으로부터 추출한 시험액을 각각 30 ㎕ 분주한 후 30℃ 인큐베이터에서 24시간 동안 반응시키고, 효소반응이 진행된 플레이트에 루골요오드용액을 플레이트가 충분히 덮이도록 분주한 후 나타나는 환의 크기로 아밀라제의 활성을 비교하였다. 분해된 전분은 반투명색, 미분해된 전분은 루골요오드용액에 의해 진한 남색으로 나타나므로, 환의 크기가 클수록 효소활성이 높은 것이라 할 수 있다.The enzyme activity was measured by 30 쨉 l of the fermentation enzyme food and the test solution extracted from the product of Company C on a soluble starch plate, reacting in an incubator at 30 캜 for 24 hours, And the activity of amylase was compared with the size of the ring after the injection. The degraded starch is translucent and the undifferentiated starch is dense dark blue by the brucellosis iodine solution. Therefore, the greater the size of the ring, the higher the enzyme activity.
그 결과, 본 발명의 발효효소식품은 국내 C 제품과 비교하여 아밀라아제 활성이 우수한 것으로 나타났다(도 3).
As a result, the fermented enzyme food of the present invention showed an excellent amylase activity as compared with the domestic C product (FIG. 3).
<1-2> 프로테아제 활성 측정<1-2> Measurement of protease activity
상기 실시예 1에서 제조한 발효효소식품과 국내제품 4종 및 일본제품 1종의 프로테아제 활성을 측정하여 비교하였다. 국내제품 4종은 볶음보리, 현미, 흑미 등을 황국을 이용하여 발효한 국내 K사 제품, 흑미, 미강, 율무, 보리 등을 황국을 이용하여 발효한 N사 제품, 현미와 미강을 황국을 이용하여 발효한 C사 제품, 및 현미, 대두 등을 황국을 이용하여 발효한 것으로 여기에 다시마, 해조칼슘, 효모추추출물, 함초 등이 포함된 H사 제품을 사용하였다. 일본 K사 제품은 현미 및 대두를 주원료로 하였다. 구체적으로, 실험을 위해 0.6% 카제인 용액, 0.1N NaOH, 0.4M TCA, 0.4M 탄산나트륨 용액과 1N 폴린(Folin) 시약 및 시험액을 준비하였으며, 실험은 다음의 방법에 따라 시행하였다. 카제인용액 3 ㎖와 시험액 1 ㎖를 혼합한 후 30℃에서 10분간 반응시켰으며, 대조군으로는 시험액 대신 정제수를 사용하였다. 여기에 TCA용액 5 ㎖를 가하여 분해되지 않고 남은 단백질을 응고시킨 후 반응물을 거름종이로 걸러 응고된 미분해 단백질을 제거하였다. 여액 1 ㎖, 탄산나트륨 용액 2.5 ㎖ 및 폴린 시약 0.5 ㎖를 혼합한 후 30℃에서 30분간 발색반응을 시킨 후 660 nm에서 흡광도를 측정하였다. 표준곡선은 티로신(tyrosine)을 이용하여 작성하였으며, 프로테아제 활성은 측정된 티로신 함량을 기준으로 비교 분석하였다.The fermented enzyme food prepared in Example 1, the four kinds of domestic products and the protease activity of one kind of Japanese products were measured and compared. Domestic products are N fermented by fermented Korean rice, black rice, rice gruel, yulmu, barley, etc. fermented with fried barley, brown rice, black rice, etc. Fermented C products, and brown rice, soybean, etc. were fermented by using fermented soybeans, and H company products including kelp, seaweed calcium, yeast extract, and green tea were used. Japanese K company products mainly made of brown rice and soybeans. Specifically, 0.6% casein solution, 0.1N NaOH, 0.4M TCA, 0.4M sodium carbonate solution, 1N Folin reagent and test solution were prepared for the experiment. 3 ml of casein solution and 1 ml of test solution were mixed and reacted at 30 ° C for 10 minutes. As a control, purified water was used instead of test solution. 5 ml of TCA solution was added thereto to coagulate the remaining protein without degradation, and the reaction product was filtered with filter paper to remove the undegraded protein which solidified. 1 ml of the filtrate, 2.5 ml of the sodium carbonate solution and 0.5 ml of the pallin reagent were mixed, followed by color development at 30 ° C for 30 minutes, and the absorbance at 660 nm was measured. Standard curves were prepared using tyrosine, and protease activity was compared and analyzed based on the measured tyrosine content.
그 결과, 본 발명의 발효효소식품에 함유된 프로테아제 활성은 티로신 81.46 ppm으로 측정되었고, 이는 국내 제품 4종과 일본 제품 1종의 프로테아제 활성과 비교하여 월등히 높은 수치인 것을 알 수 있었다(도 4).
As a result, the protease activity contained in the fermentation enzyme food of the present invention was found to be 81.46 ppm of tyrosine, which was much higher than the protease activity of four domestic products and one Japanese product (Fig. 4) .
<< 실험예Experimental Example 2> 발효효소식품의 항산화 효능의 확인 2> Identification of antioxidant efficacy of fermented enzyme food
<2-1> 폴리페놀의 함량 측정<2-1> Determination of polyphenol content
본 발명의 발효효소식품이 갖는 총 폴리페놀의 함량을 상기 프로테아제 활성 측정에서 언급한 국내제품 4종 및 일본제품 1종과 함께 측정하여 비교하였다. 시험액은 상기 아밀라아제 및 프로테아제 측정을 위한 시험액 제조와 동일한 방법으로 제조하였으며, 정제수 90 ㎖에 2N 폴린 시약 10 ㎖를 혼합하여 0.2N 폴린 시약을 제조하였고, 53 g의 탄산나트륨을 정제수에 용해한 후 총 부피를 1 ㎖가 되도록 맞춰 1N 탄산나트륨 용액을 준비하였다. 총 폴리페놀은 시험액 50 ㎕에 450 ㎕ 증류수와 0.2N 폴린 용액 2.5 ㎖를 가하여 충분히 교반한 후 5분간 방치하고 1N 탄산나트륨용액 2 ㎖를 가하여 30℃에서 30분간 반응시킨 후 765 nm에서 흡광도를 측정하였다. 갈산(Gallic acid)을 표준물질로 사용하여 검량선을 작성한 후 총 폴리페놀 함량을 측정액 1 ℓ 중의 ㎎ 갈산(mgGAE/L)으로 나타내었다.The total polyphenol content of the fermented enzyme food of the present invention was measured and compared with the four domestic products and one Japanese product mentioned in the measurement of the protease activity. The test solution was prepared in the same manner as in the preparation of the test solution for the amylase and protease measurement, and 90 ml of purified water and 10 ml of 2N phosphoric reagent were mixed to prepare a 0.2N pallin reagent. 53 g of sodium carbonate was dissolved in purified water, 1 N sodium carbonate solution was prepared so as to be 1 ml. Total polyphenol was prepared by adding 450 μl of distilled water and 2.5 μl of 0.2N phlorin solution to 50 μl of the test solution. The solution was allowed to stand for 5 minutes, and 2 ml of 1 N sodium carbonate solution was added thereto. The reaction was carried out at 30 ° C for 30 minutes and the absorbance was measured at 765 nm . Gallic acid was used as a standard and a calibration curve was drawn. The total polyphenol content was expressed in mg of gallic acid (mg GAE / L) in 1 L of the measurement liquid.
그 결과, 본 발명의 발효효소식품에 함유된 폴리페놀은 갈산 920.678 ㎎/ℓ로 측정되었고, 이는 국내 제품 4종과 일본 제품 1종의 폴리페놀 함량과 비교하여 월등히 높은 수치인 것을 알 수 있었다(도 5).
As a result, polyphenol contained in the fermented enzyme food of the present invention was measured to be 920.678 mg / l of gallic acid, which was much higher than the content of polyphenols of four domestic products and one Japanese product ( 5).
<2-2> 발효효소식품의 항산화 효능 측정<2-2> Measurement of antioxidant efficacy of fermented enzyme food
본 발명의 발효효소식품의 항산화 효능을 확인하기 위하여, 상기 실시예 1에서 제조한 발효물을 8배 희석한 발효액과 수돗물에 각각 못을 담가 본 발명의 발효물의 항산화 효능을 확인하였다.In order to confirm the antioxidant effect of the fermented enzyme food of the present invention, the antioxidant activity of the fermented product of the present invention was confirmed by immersing the fermented product prepared in Example 1 in an 8-fold diluted fermentation liquid and tap water, respectively.
그 결과, 본 발명의 발효물에 의해 못이 녹슬지 않는 것으로 나타남으로써 항산화 효과가 있는 것을 육안으로 확인하였다(도 6). As a result, it was confirmed that the nails were not rusted by the fermented product of the present invention, thereby visually confirming that the antioxidant effect was exhibited (FIG. 6).
Claims (13)
상기 혼합물에 황국균 및 유산균을 접종하여 30℃ 이상 35℃ 미만의 온도에서 60 내지 72 시간 동안 발효하는 단계;
상기 발효물을 건조하는 단계; 및
상기 건조된 발효물을 분쇄한 후 과립, 분말, 환, 캡슐 및 정제로 이루어진 군으로부터 선택되는 어느 하나의 제형으로 가공하는 단계를 포함하는 발효효소식품의 제조방법으로서,
상기 현미 및 미강을 혼합한 혼합물은 혼합물 총 중량에 대하여 미강 1 내지 40 중량% 및 현미 1 내지 60 중량%를 포함하는 발효효소식품의 제조방법.
Mixing the mixture of brown rice and rice bran;
Fermenting the mixture for 60 to 72 hours at a temperature of 30 ° C or more and less than 35 ° C by inoculation of Hwanggyu gum and lactic acid bacteria;
Drying the fermentation product; And
The method of producing a fermented enzyme food according to claim 1, wherein the dried fermented product is pulverized and processed into a formulation selected from the group consisting of granules, powders, rings, capsules and tablets,
Wherein the mixture of the brown rice and the rice bran comprises 1 to 40% by weight of rice bran and 1 to 60% by weight of brown rice based on the total weight of the mixture.
상기 증숙은 100 내지 120℃ 온도에서 0.5 내지 3시간 동안 실시하는 것을 특징으로 하는 제조방법.
The method according to claim 1,
Wherein the steaming is carried out at a temperature of 100 to 120 DEG C for 0.5 to 3 hours.
상기 혼합물은 분말 또는 곡물 형태인 것을 특징으로 하는 제조방법.
The method according to claim 1,
Wherein the mixture is in the form of a powder or a grain.
상기 혼합물은 대두를 추가로 포함하는 것을 특징으로 하는 제조방법.
The method according to claim 1,
Characterized in that the mixture further comprises soybeans.
상기 대두는 혼합물 총 중량에 대하여 1 내지 15 중량%로 포함되는 것을 특징으로 하는 제조방법.
The method of claim 5,
Wherein the soybean is contained in an amount of 1 to 15% by weight based on the total weight of the mixture.
상기 발효 단계 전에 혼합물의 수분 함량이 혼합물의 총 중량에 대하여 55 내지 60 중량%가 되도록 수분 함량을 조절하는 단계를 추가로 포함하는 것을 특징으로 하는 제조방법.
The method according to claim 1,
Further comprising the step of adjusting the moisture content such that the moisture content of the mixture before the fermentation step is 55 to 60 wt% based on the total weight of the mixture.
상기 황국균 및 유산균은 혼합물 총 중량에 대하여 각각 0.1 내지 1.0 중량%로 접종되는 것을 특징으로 하는 제조방법.
The method according to claim 1,
Wherein said Hwangyun gum and lactic acid bacteria are inoculated at 0.1 to 1.0 wt% with respect to the total weight of the mixture.
상기 건조는 40 내지 50℃에서 5 내지 10시간 동안 실시하는 것을 특징으로 하는 제조방법.
The method according to claim 1,
Wherein the drying is carried out at 40 to 50 DEG C for 5 to 10 hours.
상기 건조된 발효물은 부원료를 추가로 포함하는 것을 특징으로 하는 제조방법.
The method according to claim 1,
Wherein the dried fermented product further comprises an additive.
상기 부원료는 스피루리나, 은행, 댓잎, 표고버섯, 도토리, 녹차, 생강, 강황, 칡, 인삼, 홍삼, 뽕잎, 더덕, 송화가루, 솔잎, 도라지, 감태, 및 비타민 B군으로 이루어진 군으로부터 선택되는 어느 하나 이상인 것을 특징으로 하는 제조방법.
The method of claim 11,
The sub ingredient may be selected from the group consisting of spirulina, bank, giant leaf, shiitake, acorn, green tea, ginger, turmeric, ginseng, ginseng, red ginseng, mulberry leaf, Gt; and / or < / RTI >
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120060604A KR101408568B1 (en) | 2012-06-05 | 2012-06-05 | Process of fermented food containing enzyme by using mixed Aspergillus oryzae and lactic acid bacteria |
PCT/KR2013/004908 WO2013183907A1 (en) | 2012-06-05 | 2013-06-04 | Method for producing fermented enzymatic food using aspergillus and lactobacillus composite fermentation technology |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120060604A KR101408568B1 (en) | 2012-06-05 | 2012-06-05 | Process of fermented food containing enzyme by using mixed Aspergillus oryzae and lactic acid bacteria |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20130136865A KR20130136865A (en) | 2013-12-13 |
KR101408568B1 true KR101408568B1 (en) | 2014-06-17 |
Family
ID=49712252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120060604A Active KR101408568B1 (en) | 2012-06-05 | 2012-06-05 | Process of fermented food containing enzyme by using mixed Aspergillus oryzae and lactic acid bacteria |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101408568B1 (en) |
WO (1) | WO2013183907A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160078075A (en) | 2014-12-24 | 2016-07-04 | (주) 미림식품 | Red ginseng pill using grain and manufacturing method of thereof |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101664453B1 (en) * | 2014-05-09 | 2016-10-10 | 고려대학교 산학협력단 | Fermented Brown Rice Having Hypocholesterolemic and Hypoglycemic Effect, Preparing Method and Use Thereof |
KR101664380B1 (en) * | 2014-08-14 | 2016-10-10 | (주)하이모 | Method for Making Fermented Food Containing Red Ginseng by Using Mixed Aspergillus Oryzae and Lactic Acid Bacteria |
US10646523B2 (en) * | 2014-10-22 | 2020-05-12 | Again Life Italia Srl | Combination comprising spirulina and palmitoylethanolamide and/or salts or pharmaceutically acceptable derivatives thereof and their formulations, for use in the prevention and/or in the treatment of hyperactivated tissue conditions |
KR101704645B1 (en) * | 2014-12-10 | 2017-02-08 | (주)하이모 | Fermented Food for Preventing Hair Loss or Promoting Hair Growth |
KR102042448B1 (en) * | 2015-04-29 | 2019-11-08 | 건국대학교 산학협력단 | Composition of Enzyme Food for Strengthening Scalp Hair and Manufacturing Method Thereof |
CN108013305A (en) * | 2016-10-28 | 2018-05-11 | 江西新华扬酵素科技有限公司 | A kind of preparation method of sprouted unpolished rice ferment drink |
KR101847995B1 (en) * | 2017-04-06 | 2018-04-11 | 사단법인 무주천마사업단 | Method for producing black Gastrodia elata pill with increased functionality and taste |
KR101968133B1 (en) * | 2017-06-28 | 2019-08-13 | 푸른솔푸드 주식회사 | Enzyme food composite manufacture method using Cirsium setidens |
KR102127911B1 (en) * | 2017-11-30 | 2020-06-29 | 주식회사 건강을 지키는 사람들 | The composition of fermented beverage for immunity enhancement and method for production thereof |
CN109938273A (en) * | 2017-12-21 | 2019-06-28 | 北京神飞航天应用技术研究院 | A kind of red yeast rice day shellfish compound formulation improving spacefarer's constitution |
CN111011712B (en) * | 2019-12-10 | 2022-05-27 | 中国农业科学院农产品加工研究所 | Fermented rice bran with intestinal probiotic activity and preparation method thereof |
KR102225000B1 (en) * | 2020-04-23 | 2021-03-09 | 주식회사 굿모닝효소 | Process for Preparing Soy Protein Powder Using Aspergillus oryzae |
KR102226019B1 (en) * | 2020-04-23 | 2021-03-10 | 주식회사 굿모닝효소 | Preparing Soy Protein Powder Using Aspergillus oryzae |
KR102190419B1 (en) * | 2020-07-23 | 2020-12-11 | 김보식 | Method of manufacturing fermented black bellflower and fermented black bellflower produced thereby |
KR102596199B1 (en) * | 2020-11-27 | 2023-10-31 | 농업회사법인 관주식품(주) | Manufacturing method of black platycodon grandiflorus increased saponin and black platycodon grandiflorus manufactured thereof |
CN113528380B (en) * | 2021-06-28 | 2023-01-20 | 国家粮食和物资储备局科学研究院 | Multi-strain composite brown rice solid-state fermentation microbial inoculum, and preparation method and application thereof |
CN113440465B (en) * | 2021-08-23 | 2022-08-26 | 云南英格生物技术有限公司 | Rice fermentation product, rice fermentation extract, preparation method and application |
KR102745848B1 (en) * | 2021-12-24 | 2024-12-23 | 강원대학교산학협력단 | Snacks and drinks for infants using lactic acid bacteria freezing-dried powder |
KR102578939B1 (en) * | 2023-07-03 | 2023-09-14 | 김준영 | Manufacturing method of rice powder comprising rice bran and rice powder comprising rice bran manufactured thereby |
CN118285503B (en) * | 2024-05-10 | 2024-11-15 | 广州秋草堂健康科技有限公司 | Preparation method of flavored four-god paste, product and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6843994B2 (en) * | 2001-03-19 | 2005-01-18 | Kabushiki Kaisha Genmai Koso | Composition of koji of rice bran and non-propagating lactic acid bacteria |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998043498A1 (en) * | 1997-04-01 | 1998-10-08 | Nichimo Co., Ltd. | Product comprising health-promotive ingredient and process for producing the same |
US20030086988A1 (en) * | 2000-12-19 | 2003-05-08 | Teruaki Iwasaki | Method for manufacturing nutricious supplement food and nutricious supplement food |
JP4304319B2 (en) * | 2003-03-05 | 2009-07-29 | 有限会社万成食品 | Koji culture method using rice koji as a substrate and brown rice koji |
KR100787756B1 (en) * | 2006-08-01 | 2007-12-24 | 김중만 | Manufacturing method of mixed culture of H. K. and Chungguk coli in soybean-rice bran mixture and processing method of the culture |
KR20090079346A (en) * | 2008-01-17 | 2009-07-22 | 송창선 | Manufacturing method of rice bran fermented food raw material using vegetable lactic acid bacteria |
KR100987990B1 (en) * | 2008-05-09 | 2010-10-18 | 원광대학교산학협력단 | Manufacturing method of rice bran-hwangkuk-chungkukyun culture mixture and processing method of the culture |
-
2012
- 2012-06-05 KR KR1020120060604A patent/KR101408568B1/en active Active
-
2013
- 2013-06-04 WO PCT/KR2013/004908 patent/WO2013183907A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6843994B2 (en) * | 2001-03-19 | 2005-01-18 | Kabushiki Kaisha Genmai Koso | Composition of koji of rice bran and non-propagating lactic acid bacteria |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160078075A (en) | 2014-12-24 | 2016-07-04 | (주) 미림식품 | Red ginseng pill using grain and manufacturing method of thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2013183907A1 (en) | 2013-12-12 |
KR20130136865A (en) | 2013-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101408568B1 (en) | Process of fermented food containing enzyme by using mixed Aspergillus oryzae and lactic acid bacteria | |
KR102134209B1 (en) | Novel strains derived from fermented food and having with excellent enzyme activity and method for producing grains-fermented food using the same | |
KR101664380B1 (en) | Method for Making Fermented Food Containing Red Ginseng by Using Mixed Aspergillus Oryzae and Lactic Acid Bacteria | |
KR101146102B1 (en) | method for manufacturing whole soybean milk containing high content of active isoflavon | |
KR101439321B1 (en) | Functional pear fermented liquid using by-product of pear processing and its application method | |
KR101261823B1 (en) | Precess of enzyme health food having high activity bymicrobial fermentation | |
CN110973423A (en) | Red yeast noni beverage and preparation method thereof | |
JP2006320257A (en) | Seaweed fermented extract, method for producing the extract, and usage of the extract | |
KR100987990B1 (en) | Manufacturing method of rice bran-hwangkuk-chungkukyun culture mixture and processing method of the culture | |
KR101955775B1 (en) | Functional fermented food additive and functionality health food manufacturing method | |
JP5081485B2 (en) | Anticancer agent and method for producing anticancer agent | |
CN101760477B (en) | Manufacturing method of blood pressure lowering red rice | |
KR20170086196A (en) | Rice bran composition and preparing method for fermented rice bran composition | |
KR20160121807A (en) | Milled grain fermentation by-products as a main component composition and the manufacturing method using this method of manufacturing a fermented food composition and the fermentation | |
CN103734852A (en) | Preparation method of aspergillus-oryzae fermented beverage based on wheat-bran bean pulp | |
KR101558134B1 (en) | Soybean paste and method for preparing the same | |
KR102061721B1 (en) | Manufacturing method of brown rice-seaweed composition fermented aspergillus | |
KR102050318B1 (en) | Fermented Rice Bran Extract and Preparing Method Thereof | |
JP3967366B1 (en) | Food material and manufacturing method thereof | |
KR100734944B1 (en) | Functional health food composition based on calcium lactate and rice bran | |
KR20020021178A (en) | functional Chungkookjang and process for preparation thereof | |
KR20140050889A (en) | Manufacturing method of sunsik with fermented grain and water soluble propolis | |
KR102691983B1 (en) | Fermented grains having gluten degradation activity, method of manufacturing the same and food composition comprising the same | |
KR102151742B1 (en) | Method for producing fermented rice bran with increased GABA content and fermented rice bran with increased GABA content produced by the same method | |
CN108782677A (en) | A kind of pumpkin tearing bread and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20120605 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20131024 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20140425 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20131024 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
AMND | Amendment | ||
PX0901 | Re-examination |
Patent event code: PX09011S01I Patent event date: 20140425 Comment text: Decision to Refuse Application Patent event code: PX09012R01I Patent event date: 20131224 Comment text: Amendment to Specification, etc. |
|
PX0701 | Decision of registration after re-examination |
Patent event date: 20140528 Comment text: Decision to Grant Registration Patent event code: PX07013S01D Patent event date: 20140523 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I Patent event date: 20140425 Comment text: Decision to Refuse Application Patent event code: PX07011S01I Patent event date: 20131224 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I |
|
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20140610 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20140610 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20170419 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20170419 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20180523 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20180523 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20190510 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20190510 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20220427 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20230515 Start annual number: 10 End annual number: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20240418 Start annual number: 11 End annual number: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20250310 Start annual number: 12 End annual number: 12 |